The research team set out to address a well-known gap in addiction science. Alcohol use disorder is strongly associated with persistent depressive and anxiety symptoms, and these delayed affective disturbances are thought to play a major role in relapse. Yet vulnerability is strikingly heterogeneous: not everyone who experiences heavy drinking and withdrawal goes on to develop the same long-term emotional consequences. Clinicians currently have no reliable way to identify, during the acute withdrawal window, which patients are most at risk. The Israeli-led team asked whether measurable signs during withdrawal, the so-called withdrawal signature, could predict later behavioral outcomes in a controlled animal model.

To do this, the researchers used a chronic intermittent ethanol exposure protocol in Sprague-Dawley rats of both sexes. Animals received five cycles of a 10 percent ethanol liquid diet, a widely used model that produces dependence-like states without requiring forced injection procedures. Control animals received a pair-fed diet, matched for calories but without alcohol, which allows researchers to separate the effects of alcohol itself from the nutritional disruptions that often accompany heavy drinking. This design is important because malnutrition and caloric imbalance can independently alter behavior and physiology, confounding many alcohol studies.

Acute withdrawal signs were assessed 12 to 24 hours after the final ethanol cycle, a window in which physical withdrawal symptoms typically peak in this model. The team recorded five neurological withdrawal signs along with body temperature and body weight change. Then came the critical part of the design: the animals were left alone for a month, a period roughly analogous to the subacute and protracted withdrawal phase in humans, before undergoing a battery of behavioral tests. These included the sucrose preference test, a standard measure of anhedonia or loss of pleasure; the elevated plus maze, which probes anxiety-like behavior through willingness to explore open, exposed arms; and the open field test, which measures both general locomotor activity and anxiety-related avoidance of open central areas.

The results confirmed that a substantial fraction of alcohol-exposed rats developed lasting behavioral abnormalities. Compared with controls, the alcohol-exposed group showed reduced sucrose preference, indicating depression-like anhedonia; reduced exploration of the open arms of the elevated plus maze, indicating anxiety-like behavior; and reduced total distance and center-zone distance in the open field, reflecting both hypoactivity and anxiety-sensitive avoidance. Depending on the specific measure, between 28.3 percent and 56.7 percent of alcohol-exposed rats met criteria for delayed behavioral abnormalities derived from the control animals’ distributions. That heterogeneity is precisely the point: the damage was real but unevenly distributed, raising the question of what distinguished the vulnerable animals from the resilient ones.

To find out, the researchers turned to principal component analysis, a statistical technique that condenses multiple correlated variables into composite scores. When applied to the five neurological withdrawal signs, the analysis yielded a single composite measure, which the authors call a Neurological Severity Score, that explained 50.4 percent of the variance in withdrawal signs. This gave the team a principled way to ask whether the overall intensity of neurological withdrawal, rather than any single symptom, carried predictive information about later emotional outcomes.

The answer was nuanced. Among the three prespecified withdrawal measures, the Neurological Severity Score, body temperature, and weight change, body temperature emerged as the most consistently informative. It showed associations with multiple delayed outcomes, including depression-like behavior, hypoactivity, and what the authors term sensitive anxiety and sensitive comorbidity, meaning anxiety measures and combined anxiety-depression measures analyzed with thresholds tuned for statistical sensitivity. Temperature-only models showed moderate internal discrimination, with optimism-corrected area under the curve values of 0.773 for sensitive anxiety and 0.735 for hypoactivity. In practical terms, an AUC of roughly 0.75 indicates a model that performs meaningfully better than chance but is far from a definitive diagnostic tool, a level the authors themselves characterize carefully.

By contrast, the composite Neurological Severity Score and body weight change did not show consistent independent associations with the delayed behavioral outcomes. This is an intriguing result, because it suggests that the intensity of overt neurological withdrawal symptoms, such as tremor and abnormal reflexes, may not be the best guide to long-term emotional risk. Body temperature, by contrast, is a systemic physiological readout. Withdrawal-associated hypothermia or temperature dysregulation could reflect deeper disruptions in thermoregulatory circuits, stress hormone systems, or inflammatory signaling that also underlie the delayed emergence of affective disturbances. The authors are appropriately cautious on this point, noting that the association does not establish causality and does not demonstrate clinical predictive value.

Indeed, the study’s limitations are as instructive as its findings. The work was conducted in a single cohort of rats, and the authors explicitly state that independent replication is required before any conclusions can be extended to humans. Behavioral measures in rodents are imperfect proxies for human depression and anxiety, and the statistical thresholds used to define abnormal behavior were derived from control animals rather than from validated clinical criteria. The moderate AUC values, while encouraging for an early-stage study, would need substantial improvement before any translation into bedside risk stratification could be contemplated. The research also received no specific external funding, and the authors declare no competing interests, details that speak to the independence of the work but also to the scale of the effort involved.

Still, the conceptual contribution is significant. The study reframes acute alcohol withdrawal not merely as an acute medical hazard to be managed and forgotten, but as a potential window of biological information about long-term psychiatric vulnerability. If the temperature finding replicates, it would be remarkable for its simplicity: a measurement that requires nothing more than a thermometer, taken during the withdrawal period, could help flag patients who need closer monitoring for post-withdrawal depression and anxiety. In a clinical world where alcohol withdrawal is often treated as a self-limiting event, the idea that its physiological signature might foreshadow the emotional aftermath a month later is a provocative and potentially practice-changing hypothesis. For now, it remains exactly that, a hypothesis awaiting replication, but one grounded in a carefully controlled animal study with both sexes represented, prespecified measures, and appropriately conservative statistical analysis. The next step will be independent cohorts, and eventually, studies in human patients, to determine whether the body’s temperature during withdrawal truly carries a message about the mind’s future.

Subject of Research: Associations between acute alcohol withdrawal measures and delayed affective-like behavioral vulnerability after chronic intermittent ethanol exposure in rats

Article Title: Acute withdrawal signatures are associated with delayed affective-like vulnerability after chronic intermittent ethanol exposure in rats

Article References: Zlotnik, A., Gruenbaum, B. F., Negev, S., Dubilet, M., Perlov, Y., Hertz, N., Grinshpun, J., Benkovich, V., Frenkel, A., & Boyko, M. (2026). Acute withdrawal signatures are associated with delayed affective-like vulnerability after chronic intermittent ethanol exposure in rats. Translational Psychiatry. https://doi.org/10.1038/s41398-026-04503-7

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04503-7

Keywords: alcohol use disorder, ethanol withdrawal, body temperature, depression-like behavior, anxiety-like behavior, rats, chronic intermittent ethanol, anhedonia, sucrose preference, elevated plus maze, open field test, Translational Psychiatry

The research team designed their experiment around a carefully staged protocol. Male rats received methamphetamine at a dose of 5 milligrams per kilogram per day for 21 consecutive days, a regimen sufficient to produce dependence-like neurochemical changes. After this exposure phase, the animals entered a nine-week withdrawal period. During withdrawal, one group of methamphetamine-exposed rats remained sedentary, while another group undertook moderate-intensity continuous training, commonly abbreviated as MICT. Control animals received saline instead of the drug. The researchers deliberately separated their statistical comparisons into phases: first comparing saline-treated animals with methamphetamine-exposed animals to establish what the drug itself did, then comparing methamphetamine-exposed sedentary rats with methamphetamine-exposed rats that exercised, to isolate the effect of training during withdrawal. This phased analytical approach allowed the team to distinguish drug effects from exercise effects rather than conflating the two.

Behaviorally, the consequences of methamphetamine exposure were stark. Using the open field test, a classic behavioral assay in which an animal is placed in an arena and its movements are tracked, the researchers found that methamphetamine-exposed rats traveled significantly shorter total distances, moved at lower velocities, and reared up on their hind legs less often than saline-treated controls. Rearing is generally interpreted as a marker of exploratory motivation and vertical activity, so its reduction signaled blunted curiosity and diminished spontaneous locomotion. Intriguingly, the methamphetamine-exposed animals showed a significant increase in grooming behavior, a repetitive self-directed action that in this context is often read as a stress-related or stereotyped response. Together, the pattern described animals that were less mobile, less exploratory, and more prone to repetitive behavior, a constellation consistent with the frontal cortical dysfunction that chronic stimulant exposure is known to produce.

To understand what was happening inside the frontal cortex, the team turned to real-time polymerase chain reaction, a technique that quantifies how actively specific genes are being transcribed into messenger RNA. They focused on a panel of seven genes: C/EBPβ, DDIT4, TSC-2, mTOR, LC3-II, Nrg-1, and EphB1. Several of these sit at the heart of the autophagy machinery, the cellular recycling system that engulfs damaged proteins and organelles and delivers them to lysosomes for degradation. LC3-II is a widely used molecular marker of autophagosome formation, while mTOR, the mechanistic target of rapamycin, is the master negative regulator of autophagy initiation. Upstream of mTOR, TSC-2 acts as a brake on mTOR signaling, and DDIT4, also known as REDD1, is a stress-induced protein that suppresses mTOR activity. C/EBPβ is a transcription factor that can drive the expression of autophagy genes under stress. Nrg-1 and EphB1, by contrast, are involved in neural development, synaptic signaling, and neuronal resilience.

The molecular readout after methamphetamine exposure told a coherent story of dysregulated autophagy signaling. Compared with saline controls, the methamphetamine-exposed rats showed significantly increased expression of C/EBPβ, DDIT4, TSC-2, and LC3-II in the frontal cortex, alongside significantly decreased expression of mTOR, Nrg-1, and EphB1. In plain terms, the drug appeared to push the autophagy system toward overactivation: the mTOR pathway, which normally keeps autophagy in check, was suppressed, while the upstream activators and the autophagosome marker LC3-II were elevated. At the same time, the reduced expression of Nrg-1 and EphB1 pointed to compromised support for synaptic maintenance and neuronal signaling. Because the frontal cortex governs executive function, decision-making, and behavioral inhibition, this molecular shift offers a plausible mechanistic bridge to the impaired locomotor and exploratory behavior observed in the open field.

The most striking results emerged when the researchers examined what happened after nine weeks of withdrawal, with or without exercise. In the sedentary methamphetamine-withdrawn group, many of the drug-induced alterations persisted. But in the group that performed moderate-intensity continuous training during withdrawal, the picture changed substantially. Exercise significantly increased total distance traveled and rearing behavior in the open field test, indicating restored locomotor activity and exploratory drive, and it significantly decreased grooming behavior, suggesting a reduction in the stress-linked repetitive responding that methamphetamine had amplified. These were not subtle statistical artifacts; the exercised animals behaved measurably more like healthy controls than their sedentary withdrawing counterparts did.

At the molecular level, the exercise intervention produced a pattern that was almost a mirror image of the drug’s effects. Moderate-intensity continuous training significantly reduced LC3-II expression, the marker of autophagosome formation that methamphetamine had driven upward, and it significantly increased the expression of mTOR, Nrg-1, and EphB1, the genes the drug had suppressed. In other words, exercise appeared to rebalance the autophagy signaling network, pulling it back from the overactivated state that chronic methamphetamine exposure had imposed, while simultaneously restoring the expression of genes that support synaptic integrity and neuronal communication. The authors interpret this as evidence that MICT attenuates the molecular impairments caused by methamphetamine in the frontal cortex, and that this molecular rebalancing accompanies, and may underpin, the behavioral recovery observed in the open field.

The significance of these findings lies partly in what they suggest about the biology of addiction recovery. Autophagy is a double-edged sword in the addicted brain: it is essential for clearing toxic protein aggregates and damaged mitochondria, but excessive or poorly regulated autophagic activity can contribute to neuronal dysfunction and cell death. Methamphetamine is known to generate oxidative stress, mitochondrial damage, and protein misfolding in dopaminergic and cortical neurons, and an overdriven autophagy response is one plausible downstream consequence. By restoring mTOR activity and reducing LC3-II, exercise may have recalibrated this system toward a healthier set point. Meanwhile, the recovery of Nrg-1 and EphB1 expression hints that exercise supports the synaptic and neurotrophic machinery that stimulant drugs erode, potentially facilitating the repair of cortical circuits involved in craving, impulse control, and reward processing.

The study also carries practical implications, though the authors are careful to frame them within the limits of an animal model. Exercise-based interventions are inexpensive, widely scalable, and largely free of the side effects that complicate pharmacological treatments for stimulant use disorder, for which no approved medications currently exist. If the mechanisms observed in rats translate even partially to humans, structured moderate aerobic exercise during early recovery could serve as an adjunct therapy that eases the behavioral disturbances of withdrawal while promoting molecular repair in the prefrontal regions most damaged by methamphetamine. Rehabilitation programs for people recovering from stimulant addiction increasingly incorporate physical activity, and this study provides a mechanistic rationale for that practice, linking a specific exercise intensity to specific gene expression changes in a specific brain region.

Caveats remain, as they always do in translational neuroscience. Rats are not people, the dose and duration of methamphetamine exposure in the laboratory do not perfectly recapitulate human patterns of use, and the open field test captures only a slice of the behavioral repertoire affected by addiction. The researchers also note that their work was conducted in compliance with the ARRIVE 2.0 guidelines and approved by the ethics committee of Hakim Sabzevari University, and that the study received no external funding. Future work will need to determine whether the autophagy-related gene changes persist after exercise stops, whether they correlate directly with neuronal survival and synaptic density, and whether other exercise modalities, such as high-intensity interval training, produce similar or different molecular signatures. For now, however, the study stands as a compelling demonstration that the brain’s recovery from methamphetamine injury is not a passive process, and that moderate, sustained exercise can actively participate in it, one gene and one behavior at a time.

Subject of Research: Effects of moderate-intensity aerobic exercise on autophagy-related gene expression and behavior in the frontal cortex during methamphetamine withdrawal in rats

Article Title: Moderate-intensity continuous training modulates the expression of autophagy-related genes in the frontal cortex and improves behavioral responses in rats during methamphetamine withdrawal

Article References: Haghighi, A. H., Izadimanesh, F., Hosseini-Kakhak, S. A., Asadi-Shekaari, M., Marefati, H., Shahrabadi, H., Iellamo, F., Farsetti, P., Bei, R., & Perrone, M. A. (2026). Moderate-intensity continuous training modulates the expression of autophagy-related genes in the frontal cortex and improves behavioral responses in rats during methamphetamine withdrawal. BMC Pharmacology and Toxicology. https://doi.org/10.1186/s40360-026-01237-6

Image Credits: AI Generated

DOI: 10.1186/s40360-026-01237-6

Keywords: methamphetamine, withdrawal, autophagy, moderate-intensity continuous training, frontal cortex, mTOR, LC3-II, open field test, exercise, neurorehabilitation, gene expression, rats